IPO - CollPlant Biotechnologies Ltd

Form Type: F-1

Filing Date: 2025-06-17

Corporate Action: Ipo

Type: New

Accession Number: 000121390025055187

Filing Summary: CollPlant Biotechnologies Ltd. has filed a registration statement under the Securities Act of 1933 on Form F-1 regarding an initial public offering (IPO) of their ordinary shares. The company focuses on regenerative and aesthetic medicine, utilizing recombinant human collagen produced through genetically engineered tobacco plants. This technology addresses needs in tissue repair and aesthetics. The offering includes 1,272,002 ordinary shares, consisting of 1,200,002 shares from private placement warrants and 72,000 from placement agent warrants. The registered direct offering closed on June 2, 2025, at a price of $3.00 per share. The document highlights significant developments, including collaborations with AbbVie for a dermal filler product that has progressed to clinical trials. The financial impact of recent geopolitical instability in Israel is also discussed, emphasizing the potential risks to operations and market conditions. The ordinary shares are listed on the Nasdaq Global Market under the symbol 'CLGN'.